We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$2.86B
AUM Growth
+$344M
Cap. Flow
+$315M
Cap. Flow %
11.01%
Top 10 Hldgs %
23.55%
Holding
1,809
New
745
Increased
318
Reduced
227
Closed
516

Sector Composition

Rank Sector Weight
1 Utilities 15.61%
2 Technology 12.98%
3 Industrials 12.91%
4 Consumer Discretionary 9.54%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCOI icon
1051
Cogent Communications
CCOI
$486M
$227K 0.01%
4,111
-1,343
-25% -$80K
MMI icon
1052
Marcus & Millichap
MMI
$1.23B
$226K 0.01%
+6,379
New +$218K
MRTN icon
1053
Marten Transport
MRTN
$1.2B
$226K 0.01%
+16,319
New +$214K
ZD icon
1054
Ziff Davis
ZD
$1.91B
$226K 0.01%
2,860
-4,271
-60% -$324K
BCSF icon
1055
Bain Capital Specialty
BCSF
$786M
$225K 0.01%
+12,093
New +$218K
CRL icon
1056
Charles River Laboratories
CRL
$14.3B
$225K 0.01%
+1,700
New +$228K
INSP icon
1057
Inspire Medical Systems
INSP
$1.78B
$225K 0.01%
+3,694
New +$243K
MKC icon
1058
McCormick & Company Non-Voting
MKC
$15.1B
$225K 0.01%
2,878
-6,922
-71% -$556K
REXR icon
1059
Rexford Industrial Realty
REXR
$8.4B
$225K 0.01%
+5,100
New +$218K
OXFD
1060
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$225K 0.01%
13,539
-9,123
-40% -$126K
BMA icon
1061
Banco Macro
BMA
$4.9B
$224K 0.01%
+8,600
New +$401K
POWL icon
1062
Powell Industries
POWL
$6.89B
$224K 0.01%
+17,202
New +$214K
TRUP icon
1063
Trupanion
TRUP
$1.39B
$224K 0.01%
+8,800
New +$258K
GTS
1064
DELISTED
Triple-S Management Corporation
GTS
$224K 0.01%
+16,735
New +$358K
FBMS
1065
DELISTED
The First Bancshares, Inc.
FBMS
$223K 0.01%
+6,900
New +$219K
PDLI
1066
DELISTED
PDL BioPharma, Inc.
PDLI
$223K 0.01%
+103,011
New +$275K
DNKN
1067
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$222K 0.01%
2,800
-29,300
-91% -$2.38M
AVP
1068
DELISTED
Avon Products, Inc.
AVP
$222K 0.01%
+50,481
New +$213K
CVSA
1069
Covista Inc
CVSA
$4.52B
$221K 0.01%
+5,800
New +$260K
CC icon
1070
Chemours
CC
$2.32B
$221K 0.01%
+14,800
New +$241K
EXEL icon
1071
Exelixis
EXEL
$13.5B
$221K 0.01%
+12,500
New +$253K
PRK icon
1072
Park National Corp
PRK
$3.68B
$221K 0.01%
2,327
-3,773
-62% -$356K
WPM icon
1073
Wheaton Precious Metals
WPM
$72.8B
$221K 0.01%
8,433
-25,590
-75% -$689K
FC icon
1074
Franklin Covey
FC
$232M
$220K 0.01%
+6,299
New +$227K
GLOB icon
1075
Globant
GLOB
$1.71B
$220K 0.01%
+2,400
New +$238K

Similar funds

Michael Gelband's Q3 2019 Portfolio in Review

As of Q3 2019, Michael Gelband held 1,809 positions worth $2.86B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Michael Gelband deployed $315M of net new capital in Q3 2019, opening 745 new positions and adding to 318 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.

By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $41.1M trimmed.

  • Michael Gelband's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
  • Michael Gelband added most to Aramark in Q3 2019, an estimated $65.8M increase.
  • Michael Gelband's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $41.1M.
  • Michael Gelband fully exited Altaba Inc in Q3 2019, selling an estimated $68.3M.
  • Michael Gelband's ten largest holdings make up 24% of its $2.86B portfolio in Q3 2019.
  • Michael Gelband opened 745 new positions and closed 516 in Q3 2019.
  • Michael Gelband's portfolio value rose 14% quarter-over-quarter to $2.86B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.